Reactive Safety Monitoring at Scale
Signal detection relies on periodic, manual analysis of large datasets. By the time signals are identified and reviewed, patient exposure has grown and regulators may already be investigating.
Common challenges in pharmacovigilance signal detection include high operational costs, slow processing times, manual errors, and scalability limitations. Traditional approaches to pharmacovigilance signal detection struggle with periodic batch analysis misses early signals between review cycles, leading to inefficiencies and missed opportunities. Organizations face increasing pressure to modernize pharmacovigilance signal detectionoperations while maintaining compliance and reducing costs.
- Periodic batch analysis misses early signals between review cycles
- Manual disproportionality analysis (PRR, ROR, EBGM) is resource-intensive and error-prone
- Fragmented data across internal safety database, public databases and literature
- No systematic integration of social media and patient forum safety signals